All In Biotech

Free tool

FAERS Monitor: Orencia

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 125118 or its brand name (Orencia, Abatacept). Reports on generic versions are filed under their own applications.

Reports

139,985

Serious

83,534

60% of reports

Hospitalization

25,730

Death reported

9,486

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective39,195
  • rheumatoid arthritis24,856
  • pain22,227
  • arthralgia21,734
  • joint swelling20,948
  • fatigue14,613
  • contraindicated product administered14,115
  • rash13,429
  • drug intolerance13,300
  • off label use12,277
  • arthropathy11,847
  • alopecia10,772
  • synovitis10,468
  • abdominal discomfort10,301
  • treatment failure10,006

Reports by year received

View as table
YearReports
200415
200512
2006346
2007470
2008778
2009313
2010867
2011562
20121,591
20132,580
20142,967
20154,561
20166,760
20179,924
201812,798
201914,017
202018,058
202113,719
202213,229
20239,505
202410,625
20259,654
20266,634

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,914,174 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
synovitisSignal10,468206.3200.4898,915
contraindicated product administeredSignal14,115130.2127.4968,418
rheumatoid arthritisSignal24,85641.841.3778,008
arthropathySignal11,84740.439.6359,334
joint swellingSignal20,94831.330.9511,408
drug intoleranceSignal13,30023.823.4251,975
treatment failureSignal10,00620.520.1163,836
abdominal discomfortSignal10,3019.89.676,665
alopeciaSignal10,7728.78.569,643
arthralgiaSignal21,7348.28.1133,500
painSignal22,2275.65.583,447
rashSignal13,4294.74.739,270
drug ineffectiveSignal39,1954.64.5113,327
fatigueSignal14,6132.92.817,944
off label useSignal12,2772.12.17,496

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.